Carbamazepine-Triggered Hemophagocytic Lymphohistiocytosis: A Case Report and Review of Literature
- 23 March 2023
- journal article
- review article
- Published by Elsevier in Pediatric Neurology
- Vol. 144, 69-71
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Analysis of the clinical characteristics of lamotrigine‐induced haemophagocytic lymphohistiocytosisJournal of Clinical Pharmacy and Therapeutics, 2022
- Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adultsBlood Research, 2021
- Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a reviewInternational Journal of Dermatology, 2020
- Hemophagocytic lymphohistiocytosis associated with oxcarbazepineThe Turkish Journal of Pediatrics, 2019
- Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 studyBlood, 2017
- HLA-associated Drug Hypersensitivity and the Prediction of Adverse Drug ReactionsPharmacogenomics, 2017
- Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and managementPediatrics International, 2016
- A hemophagocytosis syndrome attributed to phenobarbitalLa Presse Médicale, 2016
- Hemophagocytic Syndrome in Children: An Important Diagnostic Consideration in Fever of Unknown OriginClinical Infectious Diseases, 2003